Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179113 · ClinicalTrials.gov registry record · Phase 4
Esmolol Infusion During Laminectomy: Effect on Quality of Recovery
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT01179113 is a Phase 4 study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT01179113, a Phase 4 study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication.
Interventions
- DRUG Saline
- DRUG Esmolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179113
The ClinicalTrials.gov registry entry for NCT01179113 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01179113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179113 about?
NCT01179113 is a clinical study titled "Esmolol Infusion During Laminectomy: Effect on Quality of Recovery". The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication.
What is the current status of trial NCT01179113?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2011-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01179113?
The interventions under investigation include: Saline (DRUG), Esmolol (DRUG).
Who is sponsoring clinical trial NCT01179113?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.